Evaluation of Hemodynamic Parameters as Predictors of Glaucoma Progression

Table 3

Pulsatile ocular blood flow parameters.

Characteristics		DTFC	LTFC	𝑃 value
IOP average (mmHg)	baseline	19.58 (3.68)	20.96 (3.78)	.320
	1 month	17.12 (3.25)	18.01 (2.83)	.429
	6 months	17.67 (3.73)	17.71 (3.17)	.975
	12 months	17.87 (3.59)	16.48 (2.56)	.231
	18 months	16.10 (2.78)	15.23 (4.61)	.539
Pulse amplitude	Baseline	4.17 (1.50)	4.73 (1.58)	.335
	1 month	3.91 (0.88)	3.95 (1.18)	.917
	6 months	4.93 (1.88)	4.12 (1.47)	.201
	12 months	4.75 (1.40)	4.67 (1.74)	.891
	18 months	4.73 (2.78)	4.51 (1.42)	.675
Pulse volume (μL)	Baseline	7.19 (2.36)	7.81 (2.68)	.507
	1 month	7.99 (2.27)	7.60 (2.40)	.648
	6 months	8.91 (2.23)	7.07 (3.26)	.417
	12 months	9.25 (1.95)*	6.93 (3.20)*	.025*
	18 months	9.29 (2.39)*	7.82 (1.55)	.054*
POBF Baseline (μL/s)	Baseline	16.81 (4.53)	17.57 (6.13)	.702
	1 month	19.12 (4.45)	18.52 (5.48)	.754
	6 months	19.43 (4.54)	18.63 (6.21)	.69
	12 months	20.87 (4.45)	18.43 (6.51)	.242
	18 months	21.33 (2.74)	19.75 (5.61)	.336

* 𝑃<.05 statistically significant.
DTFC: dorzolamide/timolol fixed combination; LTFC: latanoprost/timolol fixed combination; IOP: intraocular pressure; POBF: pulsatile ocular blood flow.